Isolation and culture of iris pigment epithelium from iridectomy specimens of eyes with and without exfoliation syndrome

被引:22
作者
Hu, DN
McCormick, SA
Ritch, R
机构
[1] NEW YORK EYE & EAR INFIRM,DEPT OPHTHALMOL,NEW YORK,NY 10003
[2] NEW YORK EYE & EAR INFIRM,DEPT PATHOL & LAB MED,TISSUE CULTURE CTR,NEW YORK,NY
[3] NEW YORK MED COLL,VALHALLA,NY 10595
关键词
D O I
10.1001/archopht.1997.01100150091015
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To culture iris pigment epithelium (IPE) from surgical iridectomy specimens of eyes with and without exfoliation syndrome. Methods: The IPE was treated to obtain a single cell suspension. Cells were cultured in Ham F12 nutrient mixture, which was supplemented with 30% fetal bovine serum, 50-mg/mL gentamicin, and 2-mmol/L glutamine. After confluence, the cells were detached using a 0.125% trypsin-0.01% edetic acid solution, resuspended, diluted, and subcultured. The IPE from primary cultures and subcultures was studied by transmission electron microscopy. Immunocytochemical staining was performed. Results: In the primary cultures of IPE from patients with exfoliation syndrome, curved, cross-banded, fine fibrils (diameter, 10-15 nm; periodicity, 10-14 nm) were found on the cell surface. Thicker fibrils (diameter, 24-48 nm; periodicity, 24-36 nm) were found external to the fine fibrils. Subcultures contained mainly fine fibrils. The IPE cells stained positively with anticytokeratin, S100 protein, and vimentin antibodies. Conclusion: Iris pigment epithelium can be successfully cultured from eyes with exfoliation syndrome. Studying the production of exfoliation material in vitro should provide information about the pathogenesis of exfoliation syndrome and about the nature of the exfoliation material. The cultivation of normal IPE from surgical specimens provides a source for the study of the growth regulation and pharmacophysiology of IPE in vitro.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 22 条
[1]   A HISTOPATHOLOGIC STUDY OF IRIS CHANGES IN PSEUDOEXFOLIATION SYNDROME [J].
ASANO, N ;
SCHLOTZERSCHREHARDT, U ;
NAUMANN, GOH .
OPHTHALMOLOGY, 1995, 102 (09) :1279-1290
[2]  
BARISHAK Y. ROBERT, 1960, ACTA OPHTHALMOL, V38, P339
[3]  
DAVANGER M, 1980, ACTA OPHTHALMOL, V58, P520
[4]  
DAVANGER M, 1978, VONGRAEFES ARCH CLIN, V208, P65
[5]  
EAGLE RC, 1979, ARCH OPHTHALMOL-CHIC, V97, P510
[6]  
FREDDO TF, 1984, INVEST OPHTH VIS SCI, V25, P1094
[7]  
GHOSH M, 1974, CAN J OPHTHALMOL, V9, P289
[8]  
HU DN, 1992, INVEST OPHTH VIS SCI, V33, P2443
[9]  
HU DN, 1982, BIRTH DEFECTS-ORIG, V18, P67
[10]  
HU DN, 1993, INVEST OPHTH VIS SCI, V34, P1389